Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin

ConclusionThese data provide new evidence for the role of a novel multiple-active-ingredient formulation for improving skin outcomes up to 28  days following microneedling in adults with healthy skin when compared with a hyaluronic acid serum. The n-3 PUFA content of this formulation may drive accelerated inflammation resolution and wound healing alongside the complementary action of the other active ingredients, leading to the observed improvements in erythema, luminosity and skin texture.

Source: Dermatology and Therapy - October 14, 2023 Category: Dermatology Source Type: research